Form 4: Macrogenics CEO Scott Koenig Transfers Shares in Gift Transaction
SEC Form 4 Filing
Macrogenics CEO Scott Koenig gifted 374,215 shares of common stock to The Koenig 2024 Irrevocable Trust, while retaining indirect beneficial ownership.
Summary
- On September 23, 2024, Scott Koenig, the President and CEO of Macrogenics Inc. (MGNX), engaged in a transaction involving the company's common stock.
- Koenig gifted 374,215 shares of common stock.
- Following the transaction, Koenig directly owns 703,413 shares.
- Koenig also indirectly owns 374,215 shares through The Koenig 2024 Irrevocable Trust.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to a gift transaction. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like CEOs and directors, trade their company's stock. These filings provide transparency into insider transactions and can be used by investors to gauge management's sentiment and confidence in the company.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it reflects an insider's personal financial planning, but it doesn't necessarily indicate a change in the company's fundamentals.
Key Dates
| Date | Description |
|---|---|
| 09/23/2024 | Date of the gift transaction of common stock. |
| 09/25/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.